Past Papers · SAQ
Antidotes
2024B Q20
Exam questionExplain the mechanism of action by which the following drugs exert their clinical and pharmacological effect when used to treat drug toxicity or overdose, including the time taken to exert this clinical effect: (a) N-acetylcysteine (25% of marks). (b) Digoxin FAb (25% of marks). (c) Naloxone (25% of marks). (d) Lipid emulsion (i.e. Intralipid) (25% of marks).
CICMWrecks answer
Master answer
Master Compare
Compare candidate-facing canonical Pharmacopeia fields side by side. Isolated AI-draft proposals are never included.
| Field |
N-ACETYL CYSTEINE (NAC)
Antidotes · Antidotes · Level 3
|
DIGOXIN ANTIBODIES
Antidotes · Antidotes · Level 3
|
NALOXONE
Antidotes · Antidotes · Level 3
|
Intralipid 20%
Antidotes · Antidotes · Level 3
|
|---|---|---|---|---|
| Mechanism of action | - Metabolized to cysteine → Regeneration of sulphydril groups and glutathione |
Binds excess digoxin or digitoxin molecules circulating in the blood |
Reversal of MoP receptor effects such as sedation, hypotension, respiratory depression, and the dysphoric effects of partial agonists |
- unclear |
| Main Action | antioxidant and glutathione inducer |
Binds Digoxin Molecules |
competitive antagonist at mu-, delta-, |
- Energy substrate |
| Onset Peak Duration | Duration: short |
Onset: 0-60min |
Onset: 1-3 mins |
(For LA tox) |
Past papers
Exam appearances
| Exam | Exact exam wording | Candidate success |
|---|---|---|
| 2024B Q20 | Explain the mechanism of action by which the following drugs exert their clinical and pharmacological effect when used to treat drug toxicity or overdose, including the time taken to exert this clinical effect: (a) N-acetylcysteine (25% of marks). (b) Digoxin FAb (25% of marks). (c) Naloxone (25% of marks). (d) Lipid emulsion (i.e. Intralipid) (25% of marks). | 65% |